• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Hematological Tumor Global Clinical Trials Review, H1, 2012 - Product Image

Hematological Tumor Global Clinical Trials Review, H1, 2012

  • ID: 2137721
  • May 2012
  • Region: Global
  • 71 pages
  • GlobalData

Hematological Tumor Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Hematological Tumor Global Clinical Trials Review, H1, 2012" provides data on the Hematological Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematological Tumor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hematological Tumor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
Introduction
Hematological Tumor
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Hematological Tumor
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Hematological Tumor Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Sanofi-aventis
Clinical Trial Overview of Sanofi-aventis
U.S. Biotest Inc.
Clinical Trial Overview of U.S. Biotest Inc.
EUSA Pharma, Inc.
Clinical Trial Overview of EUSA Pharma, Inc.
Octagon Research Solutions, Inc.
Clinical Trial Overview of Octagon Research Solutions, Inc.
Takara Bio Inc.
Clinical Trial Overview of Takara Bio Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
Infinity Pharmaceuticals, Inc.
Clinical Trial Overview of Infinity Pharmaceuticals, Inc.
Sanofi
Clinical Trial Overview of Sanofi
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Policlinico Universitario "Agostino Gemelli"
Clinical Trial Overview of Policlinico Universitario "Agostino Gemelli"
University Hospital of Liege
Clinical Trial Overview of University Hospital of Liege
Azienda Ospedaliera di Padova
Clinical Trial Overview of Azienda Ospedaliera di Padova
King Faisal Specialist Hospital & Research Center
Clinical Trial Overview of King Faisal Specialist Hospital & Research Center
The Medical University of Graz
Clinical Trial Overview of The Medical University of Graz
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Indiana University School of Medicine
Clinical Trial Overview of Indiana University School of Medicine
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Hematological Tumor Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Hematological Tumor Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Hematological Tumor Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Hematological Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012-
Hematological Tumor Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Hematological Tumor Therapeutics Clinical Trials, North America, Top Countries, 2012-
Hematological Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Hematological Tumor Therapeutics Clinical Trials, G7 Countries, 2012-
Hematological Tumor Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Hematological Tumor Therapeutics Clinical Trials, E7 Countries, 2012-
Hematological Tumor Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Hematological Tumor Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Hematological Tumor Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Hematological Tumor Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Hematological Tumor Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Hematological Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Hematological Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Hematological Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Hematological Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-aventis, 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Biotest Inc., 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by EUSA Pharma, Inc., 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Octagon Research Solutions, Inc., 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Takara Bio Inc., 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Policlinico Universitario "Agostino Gemelli", 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Liege, 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera di Padova, 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by King Faisal Specialist Hospital & Research Center, 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2012-

List of Figures
Hematological Tumor Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Hematological Tumor Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Hematological Tumor Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Hematological Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012-
Hematological Tumor Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Hematological Tumor Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Hematological Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012-
Hematological Tumor Therapeutics Clinical Trials, G7 Countries (%), 2012-
Hematological Tumor Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Hematological Tumor Therapeutics Clinical Trials, E7 Countries (%), 2012-
Hematological Tumor Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Hematological Tumor Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Hematological Tumor Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Hematological Tumor Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Hematological Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Hematological Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Hematological Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Hematological Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos